Moreover, IL‐8 promotes ovarian cancer cell drug resistance by inducing the expression of MDR1, apoptosis inhibitor genes (Bcl‐2, Bcl‐xL, and XIAP), and by activating the Ras/MEK/ERK and PI3K/Akt signaling pathways. The gene discussed is BCL2; the disease is ovarian carcinoma.